New york stem cell foundation, the:1210698 [24-005633]
Ended Purchase Order Awarded Last action
- Contract number
- 75N92E24P00289
- Awardee
-
New York Stem Cell Foundation Inc. UEI ZCKCL8KFL3B9
- Awarding agency
-
National Human Genome Research Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $15,375
Award facts
- Contract value 100% obligated
- $15,375.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10019, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $9,375 | |
| Original award | $6,000 |
About this award
This is a $15,375 firm-fixed-price purchase order contract awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to the New York Stem Cell Foundation, Inc., a non-profit organization. The contract is for services related to stem cell research, including generating induced pluripotent stem cell lines from patients with Alzheimer's disease and related dementias, differentiating stem cells into insulin-producing beta cells, and expanding and validating neural progenitor cells derived from induced pluripotent stem cells obtained from subjects with psychiatric conditions. The contract has an ultimate completion date of December 31, 2024 and was awarded on September 16, 2024. No set-aside designation was used for this contract. The New York Stem Cell Foundation, Inc. has also received federal grants from the National Institutes of Health, including the National Cancer Institute and National Institute of Neurological Disorders and Stroke, to support its work in areas such as ovarian cancer organoid derivation and the study of human neurotoxic reactive astrocytes using induced pluripotent stem cells.
Quick answers
Who was awarded contract 75N92E24P00289?
75N92E24P00289 was awarded to New York Stem Cell Foundation Inc. by National Human Genome Research Institute (National Institutes of Health) on September 16, 2024.
How much is contract 75N92E24P00289 worth?
The government has obligated $15,375 on 75N92E24P00289.
Was contract 75N92E24P00289 competed?
The extent of competition for 75N92E24P00289 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award